21Aug/13

Veloxis Pharmaceuticals Announces Financial Results For The First Half 2013 – Daily Markets (press release)

Veloxis Pharmaceuticals Announces Financial Results For The First Half 2013
Daily Markets (press release)
Veloxis has completed two Phase III studies of LCP-Tacro™ in kidney transplant recipients as the basis for its development programme for LCP-Tacro™ as a once-daily agent for the prophylaxis of organ rejection in kidney transplantation. The first of

and more »

21Aug/13

King's College FP7 project offers hope for new treatment for heart failure – Science Business

King’s College FP7 project offers hope for new treatment for heart failure
Science Business
However, once heart failure develops the only curative treatment is heart transplantation. By revealing this robust homing mechanism, which causes cardiac stem cells to home to and repair the heart’s damaged muscle, the findings could lead to less

and more »

21Aug/13

Heart's Own Stem Cells Offer Hope for New Treatment of Heart Failure – Fars News Agency


Fars News Agency

Heart’s Own Stem Cells Offer Hope for New Treatment of Heart Failure
Fars News Agency
However, once heart failure develops the only curative treatment is heart transplantation. By revealing this robust homing mechanism, which causes cardiac stem cells to home to and repair the heart’s damaged muscle, the findings could lead to less

and more »

19Aug/13

BusinessRadioX(r)'s The Doctors Roundtable Features Dr. Enrique Martinez – San Francisco Chronicle (press release)

BusinessRadioX(r)’s The Doctors Roundtable Features Dr. Enrique Martinez
San Francisco Chronicle (press release)
Dr. Martínez has been widely published in both textbooks and peer-reviewed journals and is a noted lecturer on liver disease, liver transplantation and hepatitis. He serves as Medical Co-Director of Atlanta Gastroenterology Associates’ Liver Center.

and more »